WMT

109.95

+0.68%↑

COST

910.64

+0.27%↑

PG

148.01

-0.23%↓

KO

72.94

-0.11%↓

PM

157.14

+0.29%↑

WMT

109.95

+0.68%↑

COST

910.64

+0.27%↑

PG

148.01

-0.23%↓

KO

72.94

-0.11%↓

PM

157.14

+0.29%↑

WMT

109.95

+0.68%↑

COST

910.64

+0.27%↑

PG

148.01

-0.23%↓

KO

72.94

-0.11%↓

PM

157.14

+0.29%↑

WMT

109.95

+0.68%↑

COST

910.64

+0.27%↑

PG

148.01

-0.23%↓

KO

72.94

-0.11%↓

PM

157.14

+0.29%↑

WMT

109.95

+0.68%↑

COST

910.64

+0.27%↑

PG

148.01

-0.23%↓

KO

72.94

-0.11%↓

PM

157.14

+0.29%↑

Search

USANA Health Sciences Inc

Atidarymo kaina

19.81 -1.1

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

19.62

Max

19.95

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-17M

-6.7M

Pardavimai

-22M

214M

P/E

Sektoriaus vid.

21.733

27.583

Pelnas, tenkantis vienai akcijai

-0.15

Pelno marža

-3.118

Darbuotojai

1,700

EBITDA

-17M

11M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+94.71% upside

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-24M

358M

Ankstesnė atidarymo kaina

20.91

Ankstesnė uždarymo kaina

19.81

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

USANA Health Sciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-27 16:49; UTC

Įsigijimai, susijungimai, perėmimai

Deutsche Boerse in Talks to Buy Fund-Tech Platform Allfunds in $6 Billion Deal

2025-11-27 15:32; UTC

Įsigijimai, susijungimai, perėmimai

TotalEnergies, Repsol in Talks to Combine U.K. North Sea Assets, Cinco Dias Says, Citing Sources

2025-11-27 23:50; UTC

Rinkos pokalbiai

Nikkei May Trade Rangebound Amid Caution Over Economic Outlook -- Market Talk

2025-11-27 23:50; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-11-27 16:05; UTC

Rinkos pokalbiai

Canadian Job Vacancies Rise for Fist Time Since Start of 2024 -- Market Talk

2025-11-27 16:04; UTC

Rinkos pokalbiai

Canadian Payroll Employment Pulls Back in September, Offsetting Recent Gains -- Market Talk

2025-11-27 15:54; UTC

Įsigijimai, susijungimai, perėmimai

Allfunds Shares Rise 21% After Deutsche Boerse Says Started Acquisition Talks

2025-11-27 15:44; UTC

Įsigijimai, susijungimai, perėmimai

Deutsche Boerse: No Certainty Talks Will Result in Transaction

2025-11-27 15:43; UTC

Įsigijimai, susijungimai, perėmimai

Deutsche Boerse: Allfunds Board of Directors Has Agreed to Enter Exclusive Talks

2025-11-27 15:42; UTC

Įsigijimai, susijungimai, perėmimai

Deutsche Boerse: Nonbinding Proposal is To Acquire Allfunds at EUR8.80 a Share

2025-11-27 15:41; UTC

Įsigijimai, susijungimai, perėmimai

Deutsche Boerse in Talks With Allfunds on Possible Acquisition

2025-11-27 15:11; UTC

Rinkos pokalbiai

Dollar Could Fall in 2026 as U.S. Rate Cuts Bite -- Market Talk

2025-11-27 14:26; UTC

Rinkos pokalbiai

Hermes' Outperformance Gap Could Narrow -- Market Talk

2025-11-27 14:11; UTC

Rinkos pokalbiai

Lack of Major Budget Surprises Don't Justify Continued Sterling Strength -- Market Talk

2025-11-27 14:11; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2025-11-27 13:35; UTC

Rinkos pokalbiai

Richemont Looks Set to Continue Outgrowing Peers -- Market Talk

2025-11-27 13:33; UTC

Rinkos pokalbiai

Sterling's Post-Budget Gains Are Probably Over -- Market Talk

2025-11-27 13:22; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-11-27 13:22; UTC

Rinkos pokalbiai

Kering's Plan to Revive Gucci Needs More Clarity -- Market Talk

2025-11-27 13:17; UTC

Rinkos pokalbiai

LVMH Should Be Able to Recover Next Year -- Market Talk

2025-11-27 11:13; UTC

Rinkos pokalbiai

European Gas Prices Come Under Pressure -- Market Talk

2025-11-27 11:07; UTC

Uždarbis

Genting: Positive About Prospects Over Longer Term

2025-11-27 11:06; UTC

Uždarbis

Genting: Cautious on Near-Term Prospects of Leisure, Hospitality Industry

2025-11-27 11:04; UTC

Uždarbis

Genting: International Travel Demand Expected to Remain Resilient

2025-11-27 11:04; UTC

Uždarbis

Genting: Global Growth Expected to Remain Subdued

2025-11-27 11:04; UTC

Uždarbis

Genting: Ebitda Partly Weighed by Stronger Ringgit Vs. Singapore Dollar, British Pound, U.S. Dollar

2025-11-27 10:59; UTC

Uždarbis

Genting Bhd 3Q Net Profit Fell 86% on Year

2025-11-27 10:58; UTC

Uždarbis

Genting Bhd 3Q Rev Rose 14% on Year

2025-11-27 10:56; UTC

Uždarbis

Genting Bhd 3Q Net MYR30.3M

2025-11-27 10:56; UTC

Uždarbis

Genting Bhd 3Q EPS MYR0.0079

Akcijų palyginimas

Kainos pokytis

USANA Health Sciences Inc Prognozė

Kainos tikslas

By TipRanks

94.71% į viršų

12 mėnesių prognozė

Vidutinis 39 USD  94.71%

Aukščiausias 39 USD

Žemiausias 39 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines USANA Health Sciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

1 ratings

0

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

28.405 / 29.84Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Weak Bullish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

No Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat